Mitochondrial Thermogenesis Activator
Obesity / Metabolic Disorders
Pre-clinicalActive
Key Facts
About Equator Therapeutics
Equator Therapeutics is pioneering a novel approach to obesity and metabolic disease by pharmacologically stimulating mitochondrial thermogenesis, a natural calorie-burning process. The company's core technology platform enables the direct measurement and high-throughput screening of compounds that activate specific mitochondrial proteins to induce heat production. With a strong scientific foundation published in top-tier journals and an experienced leadership team, Equator is advancing a pre-clinical pipeline with the potential to address a massive, underserved market. The company is a private, pre-revenue biotech positioned at the intersection of mitochondrial biology and metabolic therapeutics.
View full company profileTherapeutic Areas
Other Obesity / Metabolic Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Oral Non-Incretin Small Molecule | Alaunos Therapeutics | Preclinical |